The role of cytokines in the control of hematopoietic cell differentiation remains controversial. Two general models for the cytokine control of hematopoietic differentiation have been proposed. In the stochastic model, cytokines provide proliferative and survival signals to the differentiating hematopoietic cell, but they do not provide specific lineage commitment signals. In the instructive model, cytokines transmit specific signals to multipotent hematopoietic cells, thereby directing lineage commitment. To distinguish between these two models with respect to granulocyte colonystimulating factor (G-CSFI and granulocytic differentiation, we used the 32Dc13 cell line, which is capable of differentiating into granulocytes in response to G-CSF. 32D cells HE GRANULOCYTE colony-stimulating factor (G-CSF) is a polypeptide growth factor that regulates the production, differentiation, and function of neutrophilic granulocytes.' Its effects are mediated through its interaction with the G-CSF receptor (G-CSFR), a member of the cytokine receptor superfamily.' The importance of G-CSF to granulopoiesis was recently shown in mice carrying a homozygous null mutation for G-CSF; these mice had approximately 20% of normal circulating neutrophils and a corresponding decrease in myeloid precursors in their bone marrow (BM).' The mechanism by which G-CSF, and hematopoietic growth factors in general, regulate hematopoiesis is controversial. Two general models for the role of cytokines in controlling hematopoietic differentiation have been proposed.' In the instructive model: cytokines transmit specific signals to multipotent hematopoietic cells directing lineage commitment. In the stochastic model,'" cytokines support the proliferation and survival of lineage committed cells. A major distinction between these two models is that in the instructive model the cytokine receptors are transmitting specific lineage commitment signals.
transfected with either bcl-2 or bcl-X, showed prolonged survival in medium containing no cytokine supplement. Cells surviving in these cultures developed the segmented nuclei characteristic of mature neutrophils. However, no induction of myeloperoxidase activity or increase in cathepsin G transcripts were detected. These data support a hybrid model for the role of G-CSF in granulocytic differentiation; although some features of granulocytic differentiation, namely nuclear segmentation, do not require G-CSF and appear therefore to be preprogrammed in 320 cells, the complete maturation of these cells to granulocytes appears to be dependent on G-CSF. delayed apoptosis upon IL-3 removal. Examination of the cells surviving in these cultures showed multilineage hematopoietic differentiation, including granulocytic differentiation. These data suggest that FDCP-Mix cells have a preprogrammed capacity for multilineage hematopoietic differentiation that is independent of hematopoietic growth factors. On the other hand, Dong et a19 recently identified point mutations in the G-CSFR of two patients with Kostmann syndrome who developed acute myeloid leukemia. Kostmann syndrome is a rare congenital disorder manifested by neutropenia and an arrest of myeloid maturation at the promyelocyte or myelocyte stage."'.'' The point mutations caused a truncation of the carboxy-terminal cytoplasmic region of the G-CSFR. Expression of the truncated receptor in a myeloid cell line yielded cells that proliferated rather than differentiated in response to G-CSF. These data suggest that the carboxy-terminal region of the G-CSFR may be transmitting specific differentiation signals.
In agreement with these data, several recent reports have identified a putative differentiation domain in the carboxy-terminal region of the G-CSFR."."
We have chosen to examine the role of G-CSF in granulocytic differentiation by using the 32Dc13 model of in vitro myeloid differentiation.
32Dcl3 (here simply designated 32D) cells are a nontumorigenic, diploid cell line that proliferates indefinitely in the presence of IL-3.I4 In the absence of IL-3 and in the presence of G-CSF, this cell line undergoes granulocytic differentiation. We generated stably transfected 32D clones that constitutively express either bcl-2 or bcl-X , and examined their survival and morphology in cultures without IL-3. We show that these cells have a prolonged survival in such cultures, but do not undergo complete granulocytic differentiation without G-CSF. Antisera nnd irntnurtohlr~rfin~. Cells were washed once with RPM1 and lysed in Tris-buffered saline (TBS) containing 1% NP40.
MATERIALS AND METHODS
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-Ne0 1 mmoVL phenylmethylsulfonyl fluoride (PMSF), 0.1 UlmL aprotinin, and 10 pg/mL leupeptin and incubated at 4°C for I O minutes. Insoluble material was removed by centrifugation at 10,OOOg for 10 minutes at 4°C. For immunoblotting, approximately 30 pg of protein from each sample was separated on a 16.5% sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) gel and transferred to nitrocellulose. After blocking overnight in a solution of TBS containing 2% nonfat dry milk and I % Tween 20, membranes were incubated with the primary antibody in blocking buffer for 2 hours at room temperature. The &cl-2 antibody (6C8),I7 a hamster monoclonal specific for human bcl-2, and the bcl-X, rabbit antisera" were used at dilutions of 1 :200 and 1:l ,O00 respectively (both antibodies were a gift of Dr Stanley Korsmeyer). After washing, the bcl-2 immunoblot was sequentially incubated with a biotinylated goat-antihamster IgG antiserum (Caltag, San Francisco, CA) at a dilution of 1 :2,000 and horseradish peroxidase (HRP)-conjugated streptavidin (Zymed, San Francisco, CA) at a 1:20,000 dilution. The bcl-XL blot was hybridized with an HRP-conjugated polyclonal antirabbit antibody (Amersham, Arlington Heights, IL) at a 1:5,OOO dilution. Both blots were developed using the Enhanced Chemiluminescence (ECL) detection system (Amersham). To control for protein loading, the immunoblots were stripped (per protocol, ECL kit) and hybridized with an anti-p-tubulin monoclonal antibody" at a 1:500 dilution.
Cell survival assays. Cells in logarithmic growth phase were washed three times in CM and cultured in duplicate in CM at a cell density of 8 X 10'lmL. The number of viable cells was determined at the indicated times by trypan blue staining. Cell counts were performed in duplicate for each sample. Recombinant human G-
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CSF was used at a concentration of IO nglmL (Amgen, Thousand Oaks, CA).
Cell morphology and myeloperoxidase assays. Cytospins of 1 X IO4 to 1 X 10scells were made using the Cytospin 3 cytocentrifuge (Shandon, Pittsburgh, PA). Necrotic cells were removed by centrifugation through a cushion of Histopaque 1077 (Sigma, St Louis, MO) at 400g for 30 minutes. Cell morphology was assessed after MayGrlinwald-Giemsa staining. Myeloperoxidase activity was determined on cytospin specimens using a leukocyte peroxidase kit, per manufacture's recommendations (Sigma).
RNA preparation and SI nuclease protection. Total cellular RNA was prepared from cells using a guanidinium thiocyanate miniprep, as described.2" Preparation of the y-"P-end-labeled probes and S1 nuclease protection assays were performed as previously described.2' The cathepsin G probe is a genomic fragment endlabeled at a BgnI site in exon 4, as shown (see Fig 4) (a gift from Dr Timothy J. Ley, Washington University, St Louis, The murine p-actin probe is a genomic fragment end labeled at a Bgnl site in exon 2 (a gift of Dr Timothy J. Ley, unpublished sequence).
Correctly spliced murine &actin mRNA protects a 135-nucleotide probe fragment. Autoradiograms were exposed for 24 to 72 hours at -70°C.
In siru detection ofapoptosis. Cells were spun onto glass slides as described above and fixed in 1% paraformaldehyde in TBS for 30 minutes at room temperature. Endogenous peroxidase activity was blocked by incubation of samples in 0. I % H202 in TBS for 30 minutes at room temperature. DNA termini were labeled by incubation at 37°C for 1 hour in a solution containing S pmol/L digoxigenin-conjugated dUTP (Boehringer Mannheim, Indianapolis, IN) and 400 UlmL terminal deoxynucleotidyl transferase in buffer supplied by the manufacturer (Promega, Madison, WI). After washing in TBS, the slides were sequentially incubated with a sheep antidigoxigenin Fab (Boehringer Mannheim) at a 1:200 dilution and an HRP-conjugated goat-antisheep IgG antibody (Zymed, San Francisco, CA) at a 1:120 dilution. Slides were developed with the 3-amino-9-ethylcarbazole substrate per manufacturer's recommendations (Zymed, San Francisco, CA).
RESULTS
Overexpression of bcl-2 or bcl-XL in 320 cells suppresses apoptosis induced by cyrokine withdrawal. 32D cells comprise an L-3-dependent cell line that rapidly undergoes apoptosis upon cytokine ~ithdrawa1.l~ Expression of both hcl-2 and bcl-X, in 32D cells appears to be responsive to L-3; mRNA levels for both genes decrease rapidly upon IL-3 removal.23 BC/-2 overexpression has been shown to delay apoptosis in a number of cytokine-dependent cell lines upon cytokine deprivati~n.*~~*~ These data suggest that bcl-2, or a related family member, may mediate the survival signal provided by cytokines. Therefore, we tested the ability of bcl-2 and hcl-X, to suppress apoptosis in cytokine-deprived 32D cells. cDNAs for human hcl-2 or murine hcl-X,. were cloned into the expression vector pBSRaEN, and the resulting constructs transfected into 32D cells. Three clones each were isolated that contained the hcl-2, hcl-XL, or vector alone constructs (designated 32D-bc12, 32D-bcIX, or 32D-neo, respectively). The responses of the three 32D-bc12 or 32D-bclX clones in our assays were nearly identical, therefore only representative results are shown. Immunoblots of cell lysates demonstrated the appropriate expression of either bcl-2 or bcl-X, (Fig l) . These clones were examined for their survival in serum containing medium without added [L-3. 
Morphology of 32D-bc12 cells after cytokine deprivation (original magnification x 600). May-Grlinwald-Giemsa staining was performed on the following cells. (A) 32D-bc12 cells in IL-3-containing medium. (B and D) 32D-neo and 32D-bc12 cells, respectively, cultured for 7 days in medium containing 10 ng/mL of G-CSF. (C) 32D-bc12 cells cultured for 7 days in medium without G-CSF. Necrotic cells were removed by density centrifugation.
Approximately 50% of 32D-bc12 or 32D-bclX cells survived 3 days after cytokine deprivation compared with no survival of 32D-neo cells (Fig 2) . These data indicate that constitutive expression of hcl-2 or hcl-X,. is able to prolong survival in IL-3-deprived 32D cells; further, this survival advantage is similar to that achieved with G-CSF stimulation of control cells (Fig 2; neo + G-CSF). Interestingly, stimulation of 32D-bc12 or 32D-bclX cells with G-CSF had an apparent synergistic effect on cell survival (Fig 3) . A greater than fivefold higher number of viable cells were present in G-CSF-stimulated 32D-bc12 cultures when compared with either 32D-bc12 cultures without added cytokine or to 32D-neo cells cultured in G-CSF.
The phenotype of 3 2 0 cells stimulated with G-CSF is distinct from S2D-hc12 or 332D-hclX cells cultured in the absence of added cvtokine. The stochastic model of cytokine induced hematopoietic differentiation predicts that the phenotype of 32D-bc12 or 32D-bclX cells surviving in culture after cytokine deprivation should be identical to the phenotype of cells surviving in G-CSF-containing cultures. In the presence of 1L-3, all clones had an identical myeloblastic phenotype (Fig 4A and data not shown) . The morphology of cells surviving after 7 days in the indicated culture conditions is shown in Fig 4. 32D cells stimulated with G-CSF acquire many features of more mature myeloid cells, including nuclear segmentation and the appearance of cytoplasmic azurophilic granules (Fig 4B) . 32D-bc12 cells show a similar degree of nuclear segmentation, but the cells are consistently smaller with no apparent granule formation ( Fig  4C) . 32D-bc12 cells retain the ability to differentiate in response to G-CSF (Fig 4D) . Similar results were obtained with 32D-bcIX cells (data not shown).
G-CSF treatment of 32D cells is associated with the expression of a number of proteins found in the primary (azurophilic) and secondary granules of myeloid cells." The apparent lack of cytoplasmic granules in 32D-bc12 or 32D-bclX cells surviving cytokine deprivation suggested that expression of granule constituent proteins may be defective. Therefore, we examined cultured cells for their expression of myeloperoxidase, an enzyme found in the primary granules of myelomonocytic cells." Over 75% of 32D-neo and 32D-bc12 cells present after 7 days of G-CSF stimulation demonstrated myeloperoxidase activity (Fig 5B and D) . In contrast, less than 5% of 32D cells grown in IL-3-containing medium or 32D-bc12 cells surviving in cultures containing no added cytokines were myeloperoxidase positive (Fig SA and C) . Similar results were obtained with 32D-bclX cells (data not shown). ..
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. . ?.""". matopoietic serine protease found in the primary granules of myelomonocytic cells." Its mRNA expression is restricted to cells at the promyelocyte stage of myelomonocytic matuTreatment of 32D-neo or 32D-bc12 cells with G-CSF for 3 days resulted in the accumulation of cathepsin G mRNA (Fig 6, lanes 2 and 5) . No increase in the level of cathepsin G transcripts is seen in 32D-bc12 cells surviving cytokine deprivation (Fig 6, compare lanes 3 and 4) . Equivalent amounts of &actin mRNA were detected in each sample, indicating that the differences in cathepsin G mRNA expression observed in this assay are not caused by differences in RNA amount or integrity.
DISCUSSION
Hematopoietic cytokines are polypeptide soluble factors that control the growth and differentiation of hematopoietic cells. These cytokines are capable of stimulating the proliferation and enhancing the survival of the appropriate hematopoietic progenitor cell.'" However, the mechanisms by which cytokines promote hematopoietic differentiation remain controversial. Two general models for the role of cytokines in controlling hematopoietic differentiation have been proposed.' In the stochastic mode1,"'hematopoietic growth factors provide proliferative and survival signals to the differentiating hematopoietic cell, but they do not provide specific lineage-commitment signals. In the instructive model: hematopoietic growth factors provide lineage commitment, along with survival and proliferative signals. In this study, we tested these two models with respect to G-CSF and granulocytic differentiation. We used 32D cells, a cell line capable of differentiating into granulocytes in response to G-CSF.I4 The stochastic model predicts that 32D cells are already lineage committed and under permissive culture conditions will undergo granulocytic differentiation without G-CSF. Therefore, we generated 32D clones that constitutively expressed either bcl-2 or bcl-XL in an effort to circumvent the cell survival signals normally provided by G-CSF. The ability of these clones to undergo granulocytic differentiation in the absence of G-CSF was then determined.
Bcl-2 is the prototype of a family of proteins that functions to repress programmed cell death in a variety of cell lines. Bcl-2 can suppress apoptosis in a number of IL-3-dependent hematopoietic cell lines upon IL-3 withdrawal, including 32D ~ells.*~.~' Our data confirm that both bcl-2 and bcl-XL are capable of suppressing apoptosis in cytokine deprived 32D cells. Prolonged survival, up to 10 days, in IL-3-deprived cultures was noted (data not shown) and was similar to that observed in G-CSF-stimulated cultures. Interestingly, stimulation of 32D-bc12 or 32D-bclX cells with G-CSF had a synergistic effect on cell survival. This synergism raises the possibility that G-CSF mediated repression of programmed cell death may use distinct molecular pathways from bcl-2.
We have found that suppression of apoptosis in IL-3-deprived 32D cells is not sufficient to induce complete granulocytic differentiation. 32D-bc12 or 32D-bclX clones were examined for evidence of granulocytic differentiation in the presence or absence of G-CSF. In the presence of G-CSF, 32D-bc12 and 32D-bclX cells acquired many of the features of mature granulocytes including nuclear segmentation and the presence of azurophilic cytoplasmic granules. The morphology of these cells in the absence of G-CSF was distinct. The cells were consistently smaller with less abundant cytoplasm and few if any cytoplasmic granules. Interestingly, the cells cultured in the presence or absence of G-CSF had a similar degree of nuclear segmentation. To exclude the possibility that the cells with segmented nuclei were undergoing apoptosis, we performed an in situ apoptosis assay."
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Apoptotic cells were detected infrequently; further, no correlation between nuclear segmentation and apoptosis was observed (data not shown). In the presence of G-CSF, 32D-bc12 and 32D-bclX cells express myeloperoxidase and cathepsin G, proteins found in the primary granules of myelomonocytic cells. No evidence for an increased expression of these proteins was detected in the absence of G-CSF.
These data support a hybrid model for the role of G-CSF in granulocytic differentiation; although some features of granulocytic differentiation, namely nuclear segmentation, do not require G-CSF and therefore appear to be preprogrammed in 32D cells, the complete maturation of 32D cells to granulocytes appears to be dependent on G-CSF.
Fairbairn et al* reported that FDCP-Mix cells constitutively expressing bcl-2 underwent multilineage hematopoietic differentiation in the absence of exogenous cytokine. Two criteria were used to assess for granulocytic differentiation, the expression of lysozyme M and the cellular morphology after May-Griinwald-Giemsa staining. Lysozyme M is expressed predominantly in mature myelomonoctyic cells"; however, in this study expression was induced in FDCPMix cells undergoing predominantly erythroid differentiation, suggesting that in this system lysozyme M expression may not be a reliable indicator of granulocytic differentiation. On the other hand, a distinguishing feature of mature neutrophils is the segmentation of their nuclei; therefore, the appearance of cells with segmented nuclei in their serumfree cultures is indicative of granulocytic differentiation and consistent with the hypothesis that the process of nuclear segmentation that occurs during granulopoiesis is independent of G-CSF.
In the present study, we show that several features associated with granulocytic differentiation in 32D cells are dependent on G-CSF, namely induction of myeloperoxidase activity and increased cathepsin G expression. These data suggest that G-CSF, through its receptor, is transmitting specific maturation signals. This hypothesis is consistent with recent reports describing truncation mutations of the G-CSFR that are unable to mediate differentiation responses.g"." Work is in progress to define the structural motifs of the G-CSFR necessary for the differentiation response.
